Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range ...

Major stock indexes ended lower Tuesday, a day after the S&P 500 and Dow Jones Industrial Average set fresh records, as investors digested a consumer inflation reading that matched expectations and ...

Protean Small Cap returned -2.3% in November, underperforming its index by 1.3% points. Year to date, the fund’s return is 15.3%, outperforming its benchmark by 9.6%.

AI-powered medical wearables and software are flourishing following the FDA’s new hands-off regulatory guidance.

The FDA will begin accepting applications Feb. 1 for its PreCheck pilot program, an initiative designed to strengthen the domestic pharmaceutical supply chain. The program aims to increase regulatory ...

Future expansion hinges on integrating digital connectivity with lab-quality sensitivity to solidify decentralized care.

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

OpenAI is paying employees more than any tech startup in recent history, according to financial data it has shown investors. The company’s stock-based compensation is about $1.5 million per employee, ...

In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.